Method for generating a halogen-stable anti-microbial synthetic fiber

Information

  • Patent Grant
  • 10506805
  • Patent Number
    10,506,805
  • Date Filed
    Wednesday, September 19, 2018
    5 years ago
  • Date Issued
    Tuesday, December 17, 2019
    4 years ago
Abstract
A method for producing fibers with improved color and anti-microbial properties is described. One embodiment includes a method for generating a halogen stable antimicrobial synthetic fiber, the method comprising creating a mixture that includes a polymer, an anti-microbial agent, and a non-halogen pigment, and extruding the mixture to form an anti-microbial synthetic fiber.
Description
BACKGROUND OF THE PRESENT INVENTION
Field of the Present Invention

The present invention relates to fibers and fabrics designed for the effective destruction of pathogens such as bacteria, mold, mildew, fungus, spores and viruses.


Background

Anti-microbial additives containing copper, silver, gold, and zinc, either individually or combined, have been effective against pathogens such as bacteria, mold, mildew, virus, spores, and fungus. Accordingly, fibers and fabrics have been produced with anti-microbial alloys in various synthetic polymers such as polyester, polypropylene, nylon, rayon, and polylactic acid (PLA). There are many uses and applications for these types of anti-microbial fibers and fabrics, including the healthcare industry, hospitality industry, military, and infant care, among others. However, current anti-microbial fibers and fabrics have shortcomings in meeting the requirements of these uses and applications.


For example, in the healthcare and hospitality industry—such as in a hospital, nursing homes, extended care facilities, hotels, spas or the like—it is required that privacy curtains, isolation gowns, sheets, towels, scrubs, doctor's coats, bath robes, pajamas, and uniforms for medical personnel, both be sanitary and be perceived as sanitary. Therefore, the healthcare and hospitality industries require that these fabrics and garments conform to certain sanitation criteria. As there has been a rise in the possibility of contracting various contagious diseases such as Methicillin-resistant Staphylococcus aureus (MRSA) over the past few years, most in the healthcare industry now require bleaching of the towels, garments and other fabrics used in hospitals and various places where repeated use of the towels, garments and fabrics will, or is likely to, occur. This, of course, eliminates many of the types and colors of towels, garments and fabrics that can be used in the healthcare industry and is one reason why most of the fabrics are white. Moreover, because fibers and fabrics produced with known methods lose their effectiveness during repeated launderings with chlorine bleach, the laundering process required in these industries causes issues with known anti-microbial fibers and fabrics.


While the selection of white fabrics can be beneficial because of the repeated launderings, additives of copper, silver, gold, and zinc will discolor the fibers and fabrics during the life of the product, primarily due to oxidation. Accordingly, there is a need to add coloration to hide the undesirable shades created by the oxidation of the additives. In some cases, pigments have been used to color synthetic fibers by adding the pigments to the molten polymer of thermoplastic resins such as polyester, polypropylene, nylon, acrylic, or PLA. But in many cases pigments have been shown to have destructive effects on anti-microbial performance. These destructive effects are only increased due to bleach treatments that are commonly used on sanitary fabrics.


Thus the need exists for an anti-microbial fabric that will resist the destructiveness of washing in chlorine bleach and maintain its color and efficacy against pathogens. Although present fabrics and methods of making fabrics are functional, they are not sufficiently effective or otherwise satisfactory. Accordingly, a system and method are needed to address the shortfalls of present technology and to provide other new and innovative features.


SUMMARY OF THE INVENTION

Exemplary embodiments of the present invention that are shown in the drawings are summarized below. These and other embodiments are more fully described in the Detailed Description section. It is to be understood, however, that there is no intention to limit the invention to the forms described in this Summary of the Invention or in the Detailed Description. One skilled in the art can recognize that there are numerous modifications, equivalents and alternative constructions that fall within the spirit and scope of the invention as expressed in the claims.


In an embodiment, the present invention comprises a method for generating a halogen stable anti-microbial synthetic fiber, the method comprising creating a mixture, the mixture comprising a polymer, an anti-microbial agent, and a cationic pigment; and extruding the mixture to form an anti-microbial synthetic fiber. The cationic pigment may also be a non-halogen pigment, include halogen bonding sites that attract chlorine or other halogens known to be detrimental to anti-microbial fibers, and/or include an element with known anti-microbial properties. In certain embodiments, the cationic pigment may be Phthalo Blue. In yet further embodiments, Titanium Dioxide may be added to the mixture with the Phthalo Blue cationic pigment.


In another embodiment, the present invention comprises a synthetic fiber comprising a polymer, an anti-microbial agent, and a cationic pigment. The cationic pigment may also be a non-halogen pigment, include halogen bonding sites, and/or include an element with known anti-microbial properties. In certain embodiments, the cationic pigment may be Phthalo Blue. The synthetic fiber can have a density of 0.4 to 25 denier, and specifically 1.0 to 1.5 denier in some embodiments. The fiber may be in continuous form or cut to a staple length from 0.25″ to 7.5″ (6 mm to 190 mm), and specifically 1.5″ (38 mm) or 2″ (51 mm). In yet another embodiment, the fiber may be part of a continuous filament nonwoven fabric, such as a spunbond or spunmelt fabric.


As previously stated, the above-described embodiments and implementations are for illustration purposes only. Numerous other embodiments, implementations, and details of the invention are easily recognized by those of skill in the art from the following descriptions and claims.





BRIEF DESCRIPTION OF THE DRAWINGS

Various objects and advantages and a more complete understanding of the present invention are apparent and more readily appreciated by reference to the following Detailed Description and to the appended claims when taken in conjunction with the accompanying Drawings wherein:



FIG. 1 includes a flow chart for an exemplary method of producing fibers consistent with an embodiment of the present invention;



FIG. 2 shows the molecular structure of Phthalo Blue pigment, with the copper molecule at its core;



FIG. 3 shows the molecular structure of Phthalocyanine Green G pigment with 15 chlorine molecules; and



FIG. 4 shows the molecular structure of Phthalo Green 36 pigment with a combination of 16 chlorine and bromine molecules.





DETAILED DESCRIPTION

Referring now to the drawings, where like or similar elements are designated with identical reference numerals throughout the several views, and referring in particular to FIG. 1, it illustrates a method for manufacturing colored fibers with improved anti-microbial performance. At Step 100 a mixture is created, the mixture including a polymer, an anti-microbial alloy powder, and a cationic pigment. As used herein, a polymer refers to a compound suitable for fiber and fabric generation including, but not limited to, a thermoplastic polymer, polyester, nylon, rayon, polyethylene (PE), polypropylene (PP), polyethylene terephthalate (PET), polyethylene terephthalate glycol (PETG), co-PET, polylactic acid (PLA), and polytrimethylene terephthalate (PTT). In a preferred embodiment, the polymer may be polyester for durability, wrinkle resistance and color retention or nylon for its antidrip, slow burn properties.


An anti-microbial agent may be any suitable anti-microbial, such as silver, copper, zinc and/or gold in metallic forms (e.g., particulates, alloys and oxides), salts (e.g., sulfates, nitrates, acetates, citrates, and chlorides) and/or in ionic forms. In some embodiments, the anti-microbial agent is an anti-microbial alloy powder with a particle size of less than 1 micron, and preferably 0.3 to 0.6 micron.


The anti-microbial agent may be comprised of an anti-microbial powder formed from alloys of one or more metals that exhibit anti-microbial properties. Antimicrobial alloys made of two or more element alloys can have superior anti-microbial properties compared to one element particles. Embodiments of the present invention can include an anti-microbial alloy which includes a combination of: transition metals of the periodical table such as chromium, manganese, iron, cobalt, nickel, copper, zinc, silver, and/or gold; rare earth metals from the lanthanides such as cerium, neodymium, samarium, gadolinium, terbium, dysprosium, holmium, and/or erbium; and/or alkali metals such as lithium, sodium, potassium, magnesium, and/or calcium. The combination may comprise a binary combination, ternary combination, quaternary combination, or even higher order combination. The selected alloys, and the relative percentages of each alloy, may be selected depending on the intended use of the fiber or other selection criteria. Different combinations will result in different anti-microbial classes that may be used with the present invention.


For example, different classes of anti-microbial alloys have been produced by QuarTek Corporation as described in various patent applications (U.S. Provisional Application Nos. 60/888,343 and 60/821,497 filed on Aug. 4, 2006 and U.S. patent application Ser. No. 11/868,475 filed on Oct. 6, 2007, Ser. No. 11/858,157 filled on Sep. 20, 2007, and Ser. No. 11/671,675 filed on Feb. 6, 2007). These anti-microbial alloys have been produced by varying the elemental composition of the alloys, the elemental ratios within the same alloy, or by changing parameters in the synthesis process. As needed, these anti-microbial alloys may be synthesized in various size ranges from 5 nm to 2000 nm, preferably less than 1000 nm, or even within the range of 100-500 nm.


A cationic pigment is a pigment which has a positively charged molecular structure. In a preferred embodiment, the cationic pigment is a non-halogen pigment which does not include halogens such as chlorine, bromine or fluorine in its molecular structure. In another embodiment, the cationic pigment further includes halogen bonding sites that can attract chlorine or other halogens that may come into contact with the fiber, such as during laundering. These halogen bonding sites can attract and connect to a chlorine molecule or other halogen molecules and protect the alloys of copper, silver, gold, and/or zinc that provide the anti-microbial properties to the fiber. In yet further embodiments, the cationic pigment may be selected because it comprises an element with known anti-microbial properties.


For example, a preferred cationic pigment is Phthalo Blue Pigment (Phthalocyanine Blue), which has a molecular structure C32H16CuN8 as shown in FIG. 2. Phthalo Blue was chosen because, as shown in FIG. 2, it does not include a halogen, contains a Copper molecule in its core, and has 16 available sites that can attract halogen molecules such as chlorine. A halogen molecule such as chlorine can replace a hydrogen molecule and protect the alloys of copper, silver, gold, and zinc. In addition, Phthalo Blue is a brilliant blue pigment which resists fading due to bleach and sunlight. It has excellent hiding power and prevents any discoloration from the oxidation of copper, silver, or zinc. In some embodiments, Titanium Dioxide may also be added because it has excellent hiding power and softens the strong blue of Phthalo Blue. Titanium Dioxide also does not contain any chlorine molecules.


Other non-halogen pigments that may be selected include:


Egyptian Blue (Calcium Copper Silicate) CaCuS14O10


Vermillion (Mercury Sulfide) HgS


Iron Oxide Red FeO


Ultramarine Blue Na2OSAl2SiO6


Han Purple BaCuSi2O6


Paris Green (Aceto-arsenite) ({CuC2H3O2}2-3 Cu(AsO2)2)


Sheele's Green (Copper Arsenite) CuHA5O5


As indicated by Step 200 in FIG. 1, once the mixture is created, the mixture may be extruded in order to create a fiber. The extrusion process itself depends on the temperature of the mixture being sufficiently high to melt the mixture. A melting step may be a separate step in FIG. 1 or it may be part of either the mixing process or the extruding process. When the mixture is at a sufficiently high temperature, the mixture may be extruded using conventional mechanisms such as a spinneret. The fiber may then be drawn, crimped, cut and spun into a yarn or other fabric depending on the intended end use (Step 300).


An exemplary fiber consistent with the present invention was made with between 99.3% and 99.6% Polyester (PET) resin, between 0.1% and 0.4% QuarTek Alloy QSM-ACL73 and 0.3% Phthalo Blue pigment. In some embodiments, Titanium Dioxide may also be added. The compounds were extruded at a melt temperature of 290° C. and pumped through a 2400 hole spinneret to produce a fiber of 5.5 denier. The fiber was then drawn to 1.5 denier, crimped, and cut to 1.5″ (38 mm). These exemplary fibers exhibit improved visual properties and improved anti-microbial effectiveness after launderings. Fibers produced with these pigments had very poor anti-microbial properties.


In accordance with the present method, pigments such as Phthalocyanine Green G (molecular structure is shown in FIG. 3) and Phthalo Green 36 (molecular structure is shown in FIG. 4) will not be used because they contain chlorine molecules which adversely affect the anti-microbial properties of a resultant fiber.


In conclusion, the present invention provides, among other things, method for producing fibers with improved color and anti-microbial properties. Those skilled in the art can readily recognize that numerous variations and substitutions may be made in the invention, its use and its configuration to achieve substantially the same results as achieved by the embodiments described herein. Accordingly, there is no intention to limit the invention to the disclosed exemplary forms. Many variations, modifications and alternative constructions fall within the scope and spirit of the disclosed invention as expressed in the claims.

Claims
  • 1. A method for generating a halogen-stable anti-microbial synthetic fiber, the method comprising: creating a mixture comprising: a base polymer comprised at least predominantly of polyester in pellet form,an anti-microbial agent that includes silver in metallic form, salt form, or ionic form,a cationic non-halogen pigment that includes halogen bonding sites, andtitanium dioxide for softening a hue of the non-halogen pigment;heating the mixture to a melt temperature; andextruding the mixture to form an anti-microbial synthetic fiber;wherein the cationic non-halogen pigment is adapted to attract and bond with halogenic molecules at the halogen bonding sites, thereby shielding the anti-microbial agent from degradation arising from interactions with halogenic molecules.
  • 2. The method of claim 1, wherein the cationic non-halogen pigment comprises an element with known anti-microbial properties.
  • 3. The method of claim 1, wherein the cationic non-halogen pigment is phthalo blue.
  • 4. The method of claim 1, wherein the cationic non-halogen pigment is selected from the group consisting of CaCuSi4O10, HgS, FeO, Na2OSAl2SiO6, BaCuSi2O6, ({CuC2H3O2}2-3Cu(AsO2)2), and CuHA5O5.
  • 5. The method of claim 1, wherein the anti-microbial agent is in a powder form.
  • 6. A method for generating a halogen-stable anti-microbial synthetic fiber, the method comprising: creating a mixture comprising: a base polymer comprised at least predominantly of polyester in pellet form,an anti-microbial agent that includes copper in metallic form, salt form, or ionic form,a cationic non-halogen pigment that includes halogen bonding sites, andtitanium dioxide for softening a hue of the non-halogen pigment;heating the mixture to a melt temperature; andextruding the mixture to form an anti-microbial synthetic fiber;wherein the cationic non-halogen pigment is adapted to attract and bond with halogenic molecules at the halogen bonding sites, thereby shielding the anti-microbial agent from degradation arising from interactions with halogenic molecules.
  • 7. The method of claim 6, wherein the cationic non-halogen pigment comprises an element with known anti-microbial properties.
  • 8. The method of claim 6, wherein the cationic non-halogen pigment is phthalo blue.
  • 9. The method of claim 6, wherein the cationic non-halogen pigment is selected from the group consisting of CaCuSi4O10, HgS, FeO, Na2OSAl2SiO6, BaCuSi2O6, ({CuC2H3O2}2-3Cu(AsO2)2), and CuHA5O5.
  • 10. The method of claim 6, wherein the anti-microbial agent is in a powder form.
  • 11. A method for generating a halogen-stable anti-microbial synthetic fiber, the method comprising: creating a mixture comprising: a base polymer comprised at least predominantly of polyester in pellet form,an anti-microbial agent that includes silver and copper in metallic form, salt form, or ionic form,a cationic non-halogen pigment that includes halogen bonding sites, andtitanium dioxide for softening a hue of the non-halogen pigment;heating the mixture to a melt temperature; andextruding the mixture to form an anti-microbial synthetic fiber;wherein the cationic non-halogen pigment is adapted to attract and bond with halogenic molecules at the halogen bonding sites, thereby shielding the anti-microbial agent from degradation arising from interactions with halogenic molecules.
  • 12. The method of claim 11, wherein the cationic non-halogen pigment comprises an element with known anti-microbial properties.
  • 13. The method of claim 11, wherein the cationic non-halogen pigment is phthalo blue.
  • 14. The method of claim 11, wherein the cationic non-halogen pigment is selected from the group consisting of CaCuSi4O10, HgS, FeO, Na2OSAl2SiO6, BaCuSi2O6, ({CuC2H3O2}2-3Cu(AsO2)2), and CuHA5O5.
  • 15. The method of claim 11, wherein the anti-microbial agent is in a powder form.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a U.S. continuation patent application of, and claims priority under 35 U.S.C. § 120 to, U.S. nonprovisional patent application Ser. No. 15/175,398, filed Jun. 7, 2016, which '398 application published on Jan. 12, 2017 as U.S. Patent Application Publication No. US 2017/0006860 A1 and issued on Sep. 25, 2018 as U.S. Pat. No. 10,080,363, which '398 application, its publication, and the patent issuing therefrom are each incorporated by reference herein in their entirety, and which '398 application is a U.S. continuation patent application of, and claims priority under 35 U.S.C. § 120 to, U.S. nonprovisional patent application Ser. No. 14/482,123, filed Sep. 10, 2014 and now abandoned, which '123 application published on Dec. 25, 2014 as U.S. Patent Application Publication No. US 2014/0374941 A1, which '123 application and its publication are each incorporated by reference herein in their entirety, and which '123 application is a U.S. divisional patent application of, and claims priority under 35 U.S.C. § 120 to, U.S. nonprovisional patent application Ser. No. 13/276,069, filed Oct. 18, 2011 and now abandoned, which '069 application published on Apr. 19, 2012 as U.S. Patent Application Publication No. US 2012/0094120 A1, which '069 application and its publication are each incorporated by reference herein in their entirety, and which '069 application is a U.S. nonprovisional patent application of, and claims priority under 35 U.S.C. § 119(e) to, U.S. provisional patent application Ser. No. 61/394,242, filed Oct. 18, 2010, which '242 application is incorporated by reference herein in its entirety.

US Referenced Citations (60)
Number Name Date Kind
4578414 Sawyer et al. Mar 1986 A
4786556 Hu et al. Nov 1988 A
4891391 McEntee Jan 1990 A
5064599 Ando et al. Nov 1991 A
5405644 Ohsumi et al. Apr 1995 A
6384168 Tanaka et al. May 2002 B1
6723428 Foss et al. Apr 2004 B1
6841244 Foss et al. Jan 2005 B2
6946196 Foss Sep 2005 B2
8183167 Delattre et al. May 2012 B1
8193267 Burton et al. Jun 2012 B2
9878480 Grimes et al. Jan 2018 B1
9908987 Foss Mar 2018 B2
10080363 Foss Sep 2018 B2
20030204916 Green et al. Nov 2003 A1
20040018359 Haggquist Jan 2004 A1
20040096654 Morin et al. May 2004 A1
20040180200 Bertamini et al. Sep 2004 A1
20040259973 Sakuma et al. Dec 2004 A1
20050028563 Mullins et al. Feb 2005 A1
20050054830 Islam et al. Mar 2005 A1
20050191365 Creasey et al. Sep 2005 A1
20050245685 Otake et al. Nov 2005 A1
20060074154 Harashina et al. Apr 2006 A1
20060142438 Ishii et al. Jun 2006 A1
20060246149 Buchholz et al. Nov 2006 A1
20060252326 Mishler Nov 2006 A1
20080009586 VanSumeren et al. Jan 2008 A1
20080063679 Sawafta et al. Mar 2008 A1
20080090945 Langrick et al. Apr 2008 A1
20080187603 Sawafta Aug 2008 A1
20080197528 Wood Aug 2008 A1
20080242794 Sandford et al. Oct 2008 A1
20080268011 Goldmann et al. Oct 2008 A1
20080306181 Garey et al. Dec 2008 A1
20090068283 Sugiura et al. Mar 2009 A1
20090130161 Sarangapani May 2009 A1
20090218266 Sawafta et al. Sep 2009 A1
20090246258 Shukla et al. Oct 2009 A1
20090258984 Sandford et al. Oct 2009 A1
20090269379 Herbst Oct 2009 A1
20090312456 Changping Dec 2009 A1
20100124861 Wendler et al. May 2010 A1
20100136073 Preuss et al. Jun 2010 A1
20100267885 Harimoto Oct 2010 A1
20110142900 Ohta et al. Jun 2011 A1
20120083750 Sansoucy Apr 2012 A1
20120094120 Foss et al. Apr 2012 A1
20120141723 Chuah et al. Jun 2012 A1
20120164449 Foss Jun 2012 A1
20120222826 Foss et al. Sep 2012 A1
20130152737 Chen et al. Jun 2013 A1
20130209386 Cove et al. Aug 2013 A1
20140259721 Durdag et al. Sep 2014 A1
20140374941 Foss et al. Dec 2014 A1
20150044449 Foss et al. Feb 2015 A1
20150147570 Foss May 2015 A1
20150342990 Baumann Dec 2015 A1
20170006860 Foss et al. Jan 2017 A1
20170044691 Foss Feb 2017 A1
Foreign Referenced Citations (18)
Number Date Country
101705527 May 2010 CN
2655709 Oct 2013 EP
01-096244 Apr 1989 JP
01-139805 Jun 1989 JP
H02-087004 Jul 1990 JP
10-310935 Nov 1998 JP
2001-011734 Jan 2001 JP
2004-197242 Jul 2004 JP
2009-108448 May 2009 JP
10-0766418 Oct 2007 KR
2000053413 Sep 2000 WO
2007078076 Jul 2007 WO
2008010199 Jan 2008 WO
2010024423 Mar 2010 WO
2012088507 Jun 2012 WO
2012088507 Oct 2012 WO
2015023644 Feb 2015 WO
2015184347 Dec 2015 WO
Non-Patent Literature Citations (7)
Entry
Information Disclosure Statement (IDS) Letter Regarding Common Patent Application(s), dated Oct. 30, 2018.
SIGMA-ALDRICH. MSDS for Copper (II) phthalocyanine, reprinted Feb. 7, 2013 (6 pages).
Czarnobaj, K. “Sol-gel-processed silica/polydimethylsiloxane/calcium xerogels as polymeric matrices for Metronidazole delivery system.” Polym. Bull. 66:223-237 (2011) (15 pages).
“International Search Report” and “Written Opinion of the International Search Authority” (ISA/US) in Foss, Stephen W., et al., International Patent Application Serial No. PCT/US2014/050666, dated Jan. 22, 2015 (10 pages).
“International Search Report” and “Written Opinion of the International Search Authority” (ISA/KR) in Foss, Stephen W., et al., International Patent Application Serial No. PCT/US2011/067184, dated Aug. 24, 2012 (8 pages).
“European Search Report” in Foss, Stephen W., European Application No. 11850293.9, dated Apr. 16, 2014 (7 pages).
“International Preliminary Report on Patentability” in Foss, Stephen W., et al., International Patent Application Serial. No. PCT/US2014/050666, dated Feb. 16, 2016 (7 pages).
Related Publications (1)
Number Date Country
20190014775 A1 Jan 2019 US
Provisional Applications (1)
Number Date Country
61394242 Oct 2010 US
Divisions (1)
Number Date Country
Parent 13276069 Oct 2011 US
Child 14482123 US
Continuations (2)
Number Date Country
Parent 15175398 Jun 2016 US
Child 16135628 US
Parent 14482123 Sep 2014 US
Child 15175398 US